Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation Criteria in Solid Tumors or Doubling Time?
Author:
Affiliation:
1. Department of Internal Medicine and Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
2. Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Publisher
Mary Ann Liebert Inc
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.liebertpub.com/doi/pdf/10.1089/thy.2019.0341
Reference28 articles.
1. Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma
2. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
3. Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
4. Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma;Oral Oncology;2024-04
2. Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2023-12
3. Fast fully automatic detection, classification and 3D reconstruction of pulmonary nodules in CT images by local image feature analysis;Biomedical Signal Processing and Control;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3